LexisNexis® Legal Newsroom
Unlocking the Genome: The Legal Case against Genetic Diagnostic Patents

By Tiana Leia Russell* *J.D., 2005, New York University of Law; M.A., 2009, Aarhus University Excerpt from Unlocking the Genome: The Legal Case against Genetic Diagnostic Patents , 16 Marq. Intell. Prop. L. Rev. 81 (Winter 2012) I. Introduction We are on the leading edge of a true revolution...

Brinks Hofer Gilson & Lione: Federal Circuit Upholds Claims to Isolated DNA Molecules (Again)

On August 16, 2012, the Federal Circuit issued, after remand from the Supreme Court, its opinion in The Association for Molecular Pathology v. Myriad Genetics, Inc ., No. 2010-1406, slip opinion (Fed. Cir. August 16, 2012) ("Myriad") [ enhanced version available to lexis.com subscribers ]....

Certiorari Granted For A Second Time In Cancer Gene Patent Dispute

WASHINGTON, D.C. - ( Mealey's ) Less than a year after it returned to the Federal Circuit U.S. Court of Appeals a patent lawsuit over diagnostic test kits for determining hereditary risk of breast and ovarian cancer, the U.S. Supreme Court on Friday announced it will again take up the case (...

Sunstein Kann Murphy and Timbers: Supreme Court Stands to Reshape Patent Law for the Life Sciences

By Nancy Wilker, Ph.D . A member of the Life Sciences Practice Group Two thousand thirteen may end up being the year of life sciences patent law at the Supreme Court. In the last three months, the court has agreed to hear three biotech/pharma cases, the outcomes of which will have sweeping implications...